Zeskind Benjamin J. 13D and 13G filings for Immuneering Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-17 4:13 pm Purchase | 2024-12-31 | 13G | Immuneering Corporation IMRX | Zeskind Benjamin J. | 3,978,168 12.800% | 291,026 (+7.89%) | Filing |
| 2024-01-16 4:37 pm Purchase | 2023-12-31 | 13G | Immuneering Corporation IMRX | Zeskind Benjamin J. | 3,687,142 12.600% | 191,356 (+5.47%) | Filing |
| 2023-02-08 4:15 pm Purchase | 2022-12-31 | 13G | Immuneering Corporation IMRX | Zeskind Benjamin J. | 3,495,786 13.100% | 138,507 (+4.13%) | Filing |
| 2022-02-10 5:21 pm Purchase | 2021-12-31 | 13G | Immuneering Corporation IMRX | Zeskind Benjamin J. | 3,357,279 12.700% | 3,357,279 (New Position) | Filing |